Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes

被引:9
|
作者
Janssen, Joseph A. M. J. L. [1 ]
机构
[1] Erasmus MC, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands
关键词
hyperinsulinemia; overnutrition; ultra-processed foods; insulin resistance; hepatic insulin clearance and insulin resistance; prediabetes; type; 2; diabetes; bariatric surgery; VLCD diets; caloric restriction; prevention; personal fat hypothesis; ectopic fat; remission of type 2 diabetes; tirzepatide; HEPATIC INSULIN-CLEARANCE; PULSATILE INSULIN; BARIATRIC SURGERY; PLASMA-GLUCOSE; METABOLIC SYNDROME; WEIGHT-LOSS; LIVER FAT; INTRAVENOUS GLUCOSE; RISK-FACTORS; SHORT-TERM;
D O I
10.3390/ijms25105488
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The worldwide incidence of prediabetes/type 2 has continued to rise the last 40 years. In the same period, the mean daily energy intake has increased, and the quality of food has significantly changed. The chronic exposure of pancreatic beta-cells to calorie excess (excessive energy intake) and food additives may increase pancreatic insulin secretion, decrease insulin pulses and/or reduce hepatic insulin clearance, thereby causing chronic hyperinsulinemia and peripheral insulin resistance. Chronic calorie excess and hyperinsulinemia may promote lipogenesis, inhibit lipolysis and increase lipid storage in adipocytes. In addition, calorie excess and hyperinsulinemia can induce insulin resistance and contribute to progressive and excessive ectopic fat accumulation in the liver and pancreas by the conversion of excess calories into fat. The personal fat threshold hypothesis proposes that in susceptible individuals, excessive ectopic fat accumulation may eventually lead to hepatic insulin receptor resistance, the loss of pancreatic insulin secretion, hyperglycemia and the development of frank type 2 diabetes. Thus, type 2 diabetes seems (partly) to be caused by hyperinsulinemia-induced excess ectopic fat accumulation in the liver and pancreas. Increasing evidence further shows that interventions (hypocaloric diet and/or bariatric surgery), which remove ectopic fat in the liver and pancreas by introducing a negative energy balance, can normalize insulin secretion and glucose tolerance and induce the sustained biochemical remission of type 2 diabetes. This pathophysiological insight may have major implications and may cause a paradigm shift in the management of type 2 diabetes: avoiding/reducing ectopic fat accumulation in the liver and pancreas may both be essential to prevent and cure type 2 diabetes.
引用
收藏
页数:24
相关论文
共 50 条
  • [21] Translating aetiological insight into sustainable management of type 2 diabetes
    Taylor, Roy
    Barnes, Alison C.
    DIABETOLOGIA, 2018, 61 (02) : 273 - 283
  • [22] Lifestyle Intervention for Diabetes Remission: A Paradigm Shift in Diabetes Care and Management
    Tripathi, Pramod
    Kathrikolly, Thejas R.
    CURRENT DIABETES REVIEWS, 2024, 20 (09) : 45 - 49
  • [23] Role of developmental overnutrition in pediatric obesity and type 2 diabetes
    Dabelea, Dana
    Harrod, Curtis S.
    NUTRITION REVIEWS, 2013, 71 : S62 - S67
  • [24] Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes
    Risi, Renata
    Amendolara, Rocco
    Pantano, Angelo Lauria
    Fassino, Valeria
    D'Onofrio, Luca
    Coraggio, Lucia
    Luvera, Daniela
    Masi, Davide
    Watanabe, Mikiko
    Gnessi, Lucio
    Buzzetti, Raffaella
    Maddaloni, Ernesto
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [25] Dietary Protein Is Important in the Practical Management of Prediabetes and Type 2 Diabetes
    Campbell, Amy P.
    Rains, Tia M.
    JOURNAL OF NUTRITION, 2015, 145 (01) : 164 - 169
  • [26] Safety and efficacy of liraglutide on reducing visceral and ectopic fat in adults with or without type 2 diabetes mellitus: A systematic review and meta-analysis
    He, Fengling
    Chen, Wei
    Xu, Wenlong
    Liu, Dan
    Xiao, Zhiwen
    Tang, Yating
    Lin, Zhongqiu
    Liao, Yulin
    Bin, Jianping
    Chen, Guojun
    Chen, Yanmei
    DIABETES OBESITY & METABOLISM, 2023, 25 (03) : 664 - 674
  • [27] Type 2 diabetes in Brazil: epidemiology and management
    de Almeida-Pititto, Bianca
    Dias, Monike Lourenco
    Franco de Moraes, Ana Carolina
    Ferreira, Sandra R. G.
    Franco, Denise Reis
    Eliaschewitz, Freddy Goldberg
    DIABETES METABOLIC SYNDROME AND OBESITY, 2015, 8 : 17 - 28
  • [28] Antiobesity pharmacotherapy in the management of Type 2 diabetes
    Scheen, AJ
    Lefèbvre, PJ
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2000, 16 (02) : 114 - 124
  • [29] Impaired compensatory hyperinsulinemia among nonobese type 2 diabetes patients: a cross-sectional study
    Sarkar, Jit
    Maity, Sujay Krishna
    Sen, Abhishek
    Nargis, Titli
    Ray, Dipika
    Chakrabarti, Partha
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2019, 10
  • [30] Dietary fat and risk of type 2 diabetes
    Schlesinger, Sabrina
    Schwingshackl, Lukas
    Neuenschwander, Manuela
    CURRENT OPINION IN LIPIDOLOGY, 2019, 30 (01) : 37 - 43